España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Direxion Daily Healthcare Bull 3X Shares
CURE
ARCA
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$96.70
-2.03
-2.06%
At close: -
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for Direxion Daily Healthcare Bull 3X Shares (ARCA:CURE)
Direxion Daily Healthcare Bull 3X Shares (ARCA: CURE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, May 23, 2022
Markets Rise To Start The Trading Week
Henry Khederian
Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch
Melanie Schaffer
Wednesday, January 06, 2021
Direxion Leveraged Healthcare ETF Ready To Make House Calls In 2021
ETF Professor
Tuesday, December 08, 2020
Healthcare Sector Is Gonna Get Exciting, Capture That With CURE
ETF Professor
Monday, October 12, 2020
Finding A Cure For Healthcare Election Doldrums
ETF Professor
Monday, February 10, 2020
3 Leveraged Healthcare ETFs Soaring This Month
ETF Professor
Thursday, January 16, 2020
Expert: 'I've had far fewer defensive conversations than I would have expected' About The Market
Jaycee Tenn
Friday, June 07, 2019
It's Time To Consider Leveraged Healthcare ETFs
ETF Professor
Thursday, May 02, 2019
Maybe a Cure For The Health Care Blues
ETF Professor
Monday, October 15, 2018
Earnings Checkup Beckons For An Exciting Healthcare ETF
ETF Professor
Friday, July 27, 2018
Having Fun With Pharma ETFs
ETF Professor
Monday, January 22, 2018
A CURE For The Typical Healthcare Trade
Benzinga
Wednesday, November 29, 2017
CUREs For The Ordinary December Trade
Benzinga
Friday, October 06, 2017
Heaps Of Healthy Health Care ETFs
Benzinga
Monday, July 24, 2017
Two Ways To Trade This Week's Healthcare Earnings
Benzinga
Tuesday, April 04, 2017
How Leveraged Sector ETFs Performed Last Week
Benzinga
Tuesday, November 15, 2016
Don't Get SICK Of Healthcare ETFs And Stocks; Try This Instead
Benzinga
Thursday, December 03, 2015
A New Bearish Biotech ETF And A Lazarus Act For A Couple Leveraged Funds
Benzinga
Friday, August 07, 2015
To Healthcare, With Leverage
Benzinga
Sunday, February 09, 2014
Financial Times Reports Large Number of US Biotech IPOs Could Indicate Bubble is Near
Benzinga
Monday, July 29, 2013
ETFs to Watch July 29, 2013 (BOND, EWJ, IBB)
Benzinga
Wednesday, July 24, 2013
Direxion Announces Forward, Reverse Splits on 9 ETFs
Benzinga
Wednesday, October 10, 2012
Leveraged ETFs For October
Benzinga
Friday, September 14, 2012
Do ETFs With Cute Tickers Perform Better?
Benzinga
Thursday, June 28, 2012
ETFs to Watch June 28, 2012 (CURE, XBI, FCG)
Benzinga
Tuesday, June 26, 2012
Leveraged ETFs for the Obamacare Ruling
Benzinga
Monday, June 25, 2012
4 More Leveraged ETFs Your Broker Forgot to Mention (BOIL, SDP, GASX)
Benzinga
Wednesday, May 02, 2012
Nine ETFs on a Roll (DRN, TQQQ, BIB, BGU)
Benzinga
